PYPD PolyPid Ltd.
$5.77▲ +9.07%
Healthcare
Other
Volume 228.9K
Avg Volume (10D) 120.8K
Key Metrics & Fundamentals
Market Cap
$117.20M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.50 - 5.79
% vs 50 MA
12.01%
% vs 200 MA
22.50%
RSI-14
68.0
MACD Histogram
+0.0700
Beta (1Y vs SPY)
0.80
Gross Rev
$0
Gross Profit
$0
EBITDA
-$7.85M
COGS
–
Operating Exp
$7.85M
Operating Income
-$7.85M
EBIT
-$7.85M
Pretax Income
-$7.84M
Net Income
-$7.85M
EPS (Diluted)
-0.35
Price & Volume History
Loading chart…
Recent News
Oppenheimer Initiates PolyPid at Outperform With $10 Price Target
MT Newswires · Oct 27, 2026 6:36 AM ET

PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026
GlobeNewswire · Oct 21, 2026 8:00 AM ET

PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026
GlobeNewswire · Oct 15, 2026 8:30 AM ET

PolyPid Nears FDA Decision for D-PLEX100 After Strong Phase III Data
MarketBeat · Oct 4, 2026 6:02 PM ET

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
GlobeNewswire · Oct 1, 2026 9:15 AM ET

PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
GlobeNewswire · Oct 1, 2026 8:56 AM ET

PolyPid Announces Participation in Upcoming Fall Investor Conferences
GlobeNewswire · Sep 15, 2026 8:30 AM ET

PolyPid (PYPD) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 11:27 AM ET
PolyPid Ltd (PYPD) (Q2 2026) Earnings Call Highlights: FDA Priority Review and $30M Azurity ...
GuruFocus.com · Aug 12, 2026 7:03 PM ET

PolyPid Ltd. Q2 2026 Earnings Call Summary
Moby · Aug 12, 2026 5:07 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PYPD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.